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INTRODUCTION
Cancer is a disease which has been recognized since ancient times
and which in every generation has killed many victims of all ages and
of all stations in life.

The disease has been fought against from

generation to generation with whatever ideas and tools available at
that time.

Today, although cures for many diseases have been found,

cancer is still under inve�tigation and more efforts are demanded to
·oveTcome ·the disease.

In cancer chemoth�rapy, it is hoped that drugs

can be found which will have a selectively toxic effect on neoplastic
cells.

5-Fluorouracil was synthesized in 1957 by Duochinky, Pleven, and
Heidelberger and has been intensively studied.

The agent produces a

significant incidence of objective responses in patients suffering
from advanced solid tumors, particularly in breast and gastrointestinal
cancers, and prolongs the life of patients with breast carcinomas, but
at the expense of some bone marrow and gastrointestinal.toxicities.
The toxicities result from the lack of real selectivity against cancer
cells by this drug.
The cytotoxic action of nitrogen mustard compounds was first
applied to the treatment of malignant neoplasms in the 1940s following
the observation of Gilman and Philips that these agents caused
regression of certain experimental tumors, Hodgkins' disease, and
lymphosarcoma.

A nitrogen mustard derivative, cyclophosphamide,

was synthesized by Arnold, Bourseaus and Brock in 1958.

The

2

selective activity of cyclophosphamide toward cancer- cells.in com
parison to nitrogen mustards per� is of interest and induced the
research objective of synthesizing a similar derivative of 5-fluouracil
to decrease the side effects of 5-fiuorouracil.
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RESEARCH OBJECTIVE

It is believed that a significant percentage of human cancer can
be cured or at least controlled by chemotherapy, but the number of
'cures' of neoplastic disease in man that have been attained by the
use of drugs is still small.

The major stumbling block to successful

cancer chemotherapy, besides the emergence of natural or·aquired
drug-resistance, is a lack.of real selectivity against tumor cells.
This results from the close metabolic resemblance of cancer cells to
the normal cells from which they are derived.

Because of the close

similarity of normal cells and neoplastic cells, it is often necessary
to use drugs close to their toxic dosage range in order to cause
anticancer effects.

The effectiveness of most anticancer agents,

excluding the hormones, is probably related to their ability to inter
fere with cell division and hence the toxicity associated with their
use is usually encountered in the parts of the body where rapid cell
proliferation takes place, such as in the bone marrow and in the
gastrointestinal tract.

Early signs of·bone marrow toxicity are

leukopenia and thrombocytopenia. In addition to bone marrow and gas
trointestinal disturbances, the most frequently observed side reactions
are nausea and vomiting which probably result from central nervous
system disturbances (1) .

Other toxic symptoms encountered with a

number of drugs are alopecia, anorexia, hepatoxicity, and thrombo
phlebitis (2) ._ If a certain compound has a wide spectrum of toxicity
to cells, the anticancer utility of such a compound will be very
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narrow and the therapeutic index poor.

Becaus·e of this.· a: great

amount of effort has been expended in the search for compounds that are
�electively toxic to malignant tissue.

This search has met with some

success, but the compound that will destroy only malignant tissue with
little or no effect on normal cells has not, as yet, been found or
synthesized.
The discovery that mustard gas (bis-chloroethyl sulfide) resulted
in a drastic reduction in �hiteblood cell count led to research
·relative to aliphatic nitrogen mustards.�- Nitrogen mustards, as
exempµfied by mechlorethamine (I), readily cyclize under physiolog
ical conditions to the relatively stable ethylene im.inium ion (ll) then
react with available nucleophilic centers resulting in an alkylated

(denatured) substrate (III) (Fig. 1) (2).
,CHiCH2Cl
H3C-N
'CHiCH2C l

I

RAH

H�,/CH 2
,N.@
HJC 'cH�HiCl

G

Cl

II
� C;H2 CH2AR
Hf-N,
CH2cH2Cl

+

HCl

III
Fig. 1 Reaction between mechlorethamine and nucleophilic
compound (RAH).
When mechlorethamine was incubated with RNA or DNA, the major site of
alkylation was shown to be the ?-nitrogen of guanine (IV) (Fig. 2) (J).
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The alkylated form of the guanine moiety results in the deletion of the
purine from the llJA structure with the formation of labile 'apurinic
acid' (VI), and thus inhibition of DNA formation and protein synthesis

(4). Mechlorethamine is more active (5) and has been more widely used
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Fig. 2

Reaction between guanine and ethylene·iminium ion
* ethylene iminium ion
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in the treatment of cancer than an,y of its congeners.

The beneficial

results of mechlorethamine in Hodgkins ' disease and less predictably,
in other lymphomas have been extensively confirmed.

Palliative results

also have been observed in chronic leukemias, polycythem:i.a vera, and
carcinomas of the bronchus, ovary, breast, and nas opharynx ( 6).•

The

i

compound, however, cannot be referred to as .be�ng selectively toxic
because of the fact that the ef�ective dosage of this agent is often
limited by bone marrow toxicity, severe nausea, and vomiting.

For

producing more selectively toxic nitrogen mustards, several modified
forms of nitrogen mustard have been synthesized and clinically investi
gated, e. g. , l,6-bis(2-chloroethylamino)-1,6-dideoxy-D-mannitol
(degranol, VII), 3-(p- bis{2-chloroethyl)amino phenyl)-L-alanine
{melphalan, VIII), and 2- bis(2-chloroethyl)amino

tetrahydro-2H-l, 3,

2-oxazaphosphorine-2-oxide (cyclophosphamide, IX).
CH2NHCH2CH 2Cl
HOyH
HOyH
HCOH
HyOH
CH2NHCH2CH 2Cl

VII

(0
NI

VIII
p \I \

0

/

CH CH 2Cl
2

N
\ CH2CH 2Cl

IX
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The development of cyclophosphamide resulted in one of· the more
successful applications· of latentation (2) • Although the long-term
_cyclophosphamide treatment has the side effects of leukopenia, thrombo
penia and atrophy of epidermis (7), the greater specificity of cyclo
phosphamide was studied and proved in comparison with other nitrogen
mustards (mechlorethamine, normechlorethamine A (XI). etc.) (8). Due
to_deactivation by the cyclophosphamide_ moiety, the compound is not
toxic to tumor cells in .cu.lture-even · at high concentration (9), but,
·if .it is .incubated with liver homogenate;p;ior to cytotoxicity evaluation, it is highly toxic (10). These facts indicate that the

chemically inert structure may be cleaved by cellular phosphatases
and phosphamidases (11).

These enzymes do not occur in circulating

plasma and cancerous cells contain greater amounts of phosphamidases

(12) and phosphatases (13) than do normal cells.

From this reasoning,

some selectivity in toxicity could be assumed and apparently has been

exhibited (6).

Cyclophosphamide is presumed to be activated according

to the following reactions (Fig. 3).

The primary cleavage between the

phosphorus and the ring nitrogen results.in the formation of the very
stable internal salt (X).

Under physiological conditions, hydrolysis

at the nitrogen-phosphorus bond of the salt may occur so that the
toxic normechlorethamine (XI) is liberated (2).

Some dispute has been

made that metabolism of cyclophosphamide does not seem to liberate
either normechlorethamine or any other alkylating·agent (6).
In order for cellular growth to take place, biosynthesis of DNA
is essential.

If this synthesis is interfered with, cellular growth

8

I

0

u

---+ � N(CH2) -o-P-( OH)2
3
2

+

HN(CH2CH2Cl)2
XI

Fig. 3 Activation of cyclophosphamide
is impaired. An important basic component of the DNA helix is thymine
(5-methyluracil), linked as the deo,cyribonucleotide to other deoxyribo
nucleotides in the helical structure.

Since uracil is first incor

porated into 2 1 -deoJCYUridine-5 1 -phosphate and this is methylated via

the thymidylate synthetase system to give the thymine analogu�
derivative· (Fig. 4) (14). a stable group in the 5-position on the

uracil molecule would block this methylation.

The compound 5-fluorour

acil (XII) has proved this to be true.

5-Fluorouracil is a potent cytotoxic agent because it is bio-isosteric
with uracil and masquerades as uracil up to a biosynthetic point.

9
5-Fluorouracil undergoes all the degradative and anabolic reactions
or uracil with the important exception that the presence of the fluoro
group prevents methylation of the 5-carbon of 5-fluoro-2 1 -deoJCYUridine
5'monophosphat� (FUdRMP) to form thymidylic acid and inhibits thymi
dylate synthetase, an enzyme concerned with the methylation o� deo:xyuridylic acid to fonn thymidylic acid (Fig. _4) (14) . 5-Fluorouracil
has had extensive trial against.cancer in man. Clinical.responses have
been reported in a variety.of cancers including those of the large
·bowel, breast, stomach, ovary, thyroid, pancreas, cervix, pharynx
.
and ur�nary bladder (15). Because or the lack of selective toxicity,
tumor regression usually is obtained at the expense of some degree of
toxicity which may be severe. Toxicologic effects are observed in the
more rapidly proliferating tissues:

the bone marrow, the gastroin

testinal tract and sometimes, the skin, conjunctiva and vaginal and
other mucosal tissues. Severe toxicity is associated with extensive
-ulceration and hemorrhage of the gastrointestinal tract and aplasia
of the marrow (14) .
It would seem promising to incorporate onto the molecule of
5-fluorouracil a large, hydrolyzeable group that would interfere with
the bio-isosterism (masquerading as uracil) and yet could be removed
(hydrolyzed) at the desired site of action.

This should result in

a compound selectively toxic for malignant tissue if the cleavage
took place within the malignant cells•
Considering the discussion of cyclophosphamide, the synthesis
of a similar derivative of 5-fiuorouracil (XIIT) would be desirable.
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OH H
2 1 Deoxyuridylic acid
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Uridylic acid
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(5-Fluorouridine
5'monophosphate)

FUdRMP
Thymidylic acid
5 'monophosphate
Fig. 4

Synthesis of thymidylic acid 5 'monophosphate and
action mechanism of 5-fluorouracil
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This compound.would hopefully undergo cleavage undeP-the-infiuence
of malignant cellular enzymes thus liberating the bio -:. isosteric, toxic
5-fiuorouracil (Fig.

5).

Enzymes

xrn
Fig. 5 Activation of the proposed derivative of 5-fluorouracil
In order to determine the feasibility of synthesizing this 5-nuorour
�cil derivative. 5-fiuorouracil was to be synthesized and subjected to
phosphorylation reactions (Fig.

6). Although it is recognized that

the activities of uracil and 5-fluorouracil are somewhat different,
uracil was used as a test compound because it is relatively inexpen
sive and readily synthesized compared to 5-fiuorouracil.

The synthesis

of uracil (Fig. 7) and the schemes for phosphorylation of uracil are
. outlined (Fig. 8 and Fig. 9) .
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Fig. 6 Schemes for phosphorylation of 5-fluorouracil
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Fig. 7 Synthesi's of uracil
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Scheme I for phosphorylation of uracil
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Fig. 9 Scheme II for phosphorylation of uracil
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DISCUSSION
Uracil was synthesized .in a yield of 51 percent by the method
of Davidso� et al. (21). Malic acid (XVI) in fuming sulfuric acid
gave formylacetic acid (XVIII). Fifteen percent fuming sulfuric acid
was recommended; no product was obtained if more concentrated (3�)
fuming sulfuric acid was used and a poor yield (2o%) of the product
was obtained if less con�entrated (J.�) fuming sulfuric acid was
used.
Pyrimidine may be considered as a resonance hybrid of XXX, XXXI,
XXXII, IXnII {Fig. 10). Being located at the 1- and 3-positions,
the nitrogen atoms in pyrimidine cooperate in their electron directive
effects with resulting reinforcement. Thus, it is expected and

XXX

XXXI

·XXXII

XXXIII

Fig. 10 Some important resonance structures of the pyrimidine
ring
indeed pyrimidine does possess properties similar to those of pyridine,
but markedly different from benzene (29).

The 2-, 4-, and 6-positions

of pyrimidine, because of the powerful electron withdrawing effect of
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the neighboring nitrogen atoms, are electron deficient.

Halogen atoms

at these positions, like those in alkyl halides, are easily substituted
by nucleophilic agents (30) .

Since 2,4-dihalo pyrimidine possesses

activity towards substitution reactions similar to alkyl halides,
attempted reaction of 2, 4-dichloropyrimidine with the silver salt of
diethyl phosphate was applied in this research (Fig. 8). Alkyl iodides
are popularly used in these rea�tions because the carbon�iodide bond
is less stable and thus, the iodides have higher reactivity than the
other halides (Fig. 11) (31).
Iodides

>

Bromides

2, 4-DichloroPYrimidine (llX) was chosen

>

Chlorides

>

Fluorides

Increasing rate of reaction

(

Fig. 11 Reactivity of alkyl halides
as the reactant in the first synthetic attempts since it is easily
synthesized from uracil.

The dichloropyrimidine was synthesized from

uracil by the procedure of Whittaker (Fig. 12) (16).

OH

N�

HO

J(N

J

N 1 N-Dimethyl

Cl

+

II

Cl-P-Cl
I

Cl

N�

>
Cl

I

)l

N .,,-

+ HP0

3

+ HCl

·Fig. 12 Reaction between uracil and phosphoryl oxychloride
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aniline was added as a proton scavenger thus allowing a faster, more
complete reaction. When an electron withdrawing group, e.g. , fluoro,
is present at the 5-position of uracil, the conversion of hydroxy
groups with phosphoryl chloride is also successful.

In this case, for

effective reaction N, N-diethyl aniline is used (32).
Silver diethyl phosphate (XX) was synt�esized from triethyl
phosphate using the procedure of Drushel and Felty et al� (23).

The

only modification was, instead of triethyl phosphate being decomposed
�y concentrated barium hydroxide solution, a mixture of triethyl phos
phate

and

barium hydroxide in water was refluxed for one and one-half

hours (27).

In order to avoid photo instability of the silver com

pounds, reactions involving these compounds were performed in the dark.
Silver diethyl phosphate is not soluble in most organic solvents, very
soluble in water and soluble in hot dioxane.

Since the silver salt is

very unstable in hot, commercial grade dioxane, purified dioxane was
heated to about 60° for recrystalization of the salt.
The difference of electron distribution in different positions
of pyrimidine is indicated (Fig. 13) (33).

Electron density at the

2-position is more depleted by the inductive effects of the ring
nitrogen atoms than at the 4-position; therefore, in mono-nucleophilic
substitution of 2.4-dichloropyrimidine, the chloro group at the
2-position would be replaced preferencially (34).

The reaction of

2,4-dichloropyrimidine and silver diethyl phosphate was run
according to the procedure of Wolform et al. (19).

Benzene, in which

the silver salt is apparently insoluble, was used as the solvent.

The

19
+·. 0$4-

. - .o,41 N� +. 007

t .ot♦6� NJ

Fig. 13 Electron distribution of pyrimidine

molar amounts of the re�ctants were such that disubstitution was
-expected _(Fig. 8). but no product, either mono- or di-substituted

"(In), was obtained. A reaction in purified dioxane which dissolves

both of the reactants was also run. but the reaction was hindered by
the instability of the silver salt in hot dioxane. In order to increase,
the possibility of interaction between the reactants, the pyrimidine
and the silv�r salt were heated at 135° and also 155° without any

solvent,· but no product was obtained.

Reaction between alkyl halides and metallic (dialkyl) phosphates
tak�s place at the oxygen atom of the phosphoryl group since the bond
of the phosphoryl group is polar, hence �he oxygen atom carries an
appreciable negative charge and can interact with an electrophilic
center (Fig. 14) (35) . Increasing the basicity of the phosphate

(Fig. 15) would increase the negativity of the o�gen atom and might

increase the reaction rate of the nucleophillc substitution (Fig. 8).
Silver phosphate was synthesized following the procedure of Sneed
et al. (24).

To avoid 2, 4-dichloropyrimidine being hydrolized to

uracil_ in the presence of water, the silver phosphate was dried to
constant weight and commercial duodecahydrated sodium phosphate was
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dried at 105° for 12 hours to the least hydrated form.

The dried

inorganic phosphates and 2,4-dichloropyrimidine were heated according
to the method of Wolform et ·al. (19) with some modifications:

the

reaction times were lengthened and the reactions were run in an
atmosphere of nitrogen.

�-

e
C?i
,.
:o -P - OR

(i) ..

Ag

·J,

OR

Fig. 14 Mechanism of reaction between alkyl halide and silver
dialkyl phosphate
The reaction was run in the recommended solvent, benzene, and also
at 120° without any solvent.
0
II

Na0-P-ONa
I
ONa
t--Fig. 15

All of the attempts were unsuccessful.

>

0

AgO-P-OAg
II

I

>

OAg

0
II

AgO-P-OEt
.

J

OEt

Increasing basicity

Basicity of phosphates

The reason that increasing the basicity of the phosphate did not
increase the nucleophilic replacement might be due to the insolubility
of the inorganic phosphates in benzene and also to decreased reactivity

21
of 2, 4-dichloropyrimidine in comparison with alkyl chlorides.

Brown

suggests (32) that the chloro groups in 2, 4-dichloropyrimidine have
activities similar to those in aliphatic compounds, but more nearly to
that of the chloro group in chloro-2, 4-dinitrobenzene.
An attempt was made to synthesize 2,4-diiodopyrimidine because
of expected increased reactivity of the iodo over the chloro analogue
(Fig. 8).

Sodium iodide in acetone will react with alky1 chlorides to

give alkyl iodides (36).

This reaction is useful since alkyl iodides

cannot always be prepared

by

bromides.

methods used for alkyl chlorides and

The ability of the iodide ion to displace the other halo

gens is due in part to the fact that sodium iodide is soluble in
acetone while sodium. chloride is not.

The insolubility of sodium

chloride in acetone helps favor the formation of the alkyl iodide (J6) .
In an attempt to synthesize diiodopyrimidine (XXII) , two methods were
followed:

the procedure of Rosenkranz et al. (28) with acetone as

the solvent and the procedure of Kingdon and Wright (25) with 2butanone as the solvent.

2-Butanone has a higher boiling point and

thus, higher reaction temperature can be-obtained.

After refluxing,

only trace amounts of precipitate (sodium chloride?) were noticed
and the products from both methods had similar melting points (60-62 °)
as 2,4-dichloropyrimidine (61-62 ° ) indicating that the chloro groups
at the 2- and 4-positions of pyrimidine were not replaced by iodide.
In dialkyl phosphorochloridate, the phosphorus-oxygen double
bond

is

polar (35), the phosphorus being positive and electrophilic

toward nucleophiles.

This results in Sn2 replacement (Fig. 16) (37).
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,, , I
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X
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--+ R'O-P�

@0

MX

RO

Fig. 16 Reaction between metal alkoxide and dialkyl phosphoro
chloridate
With this reaction, the insecticidal agent, O, O-diethyl, 0-(2, 4-di
.methyl-6-pyrimidyi) phosphate (XXXVI) was synthesized
17) (29).
-

by

Geigy (Fig.

An attempt was made to synthesize o, 'o, o,o-tetraethyl, O,
.

,0-pyrimidine-2, 4-yl diphosphate (XXI) following the method of Geigy
(Fig. 8) .
O
Cl-�-oEt·
OEt

XXXIV

XXXV

)

CH
_J

N5

h
.,,
H CA N
3

XXXVI.

0
II
0-P-OEt

oEt

Fig. 17 Synthesis of O, O-diethyl, 0-(2, 4-dimethyl-6-pyrimidyl)
phosphate

Uracil is an acid with pKa values or·9. J8 and 12 (10) and since the
hydro:xylic proton at the 4-position is more ionizeable than the
hydroxylic proton at the 2-position (38), the mono-potassium salt
would be formed at the 4-position (XXIII). Because of this, the
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expected product would be 0, 0-diethyl, 0-(2-hydro)cy'-4-pyrimidyl) phos
phate (XXV) from reaction between diethyl phosphorochloridate (XXIV)
and the potassium salt.

Since the diethyl phosphate group at the

4-position would theoretically lower the pKa of the remaining 2hydroxy group, 0, 0-diethyl, 0-(2-hydroxy-4-pyrimidyl) phosphate.would
be capable of forming a potassium salt with potassium carbonate at the
2-position (XXVI) . Reaction of·the potassium salt with diethyl phos
phorochloridate, again, by·nucleophilic substitution, would give 0, 0
O, O�tetraethyl, O, O-pyrimidine-2, 4-yl diphosphate (XXI) . In the first
step, uracil and potassium carbonate were refluxed for three hours in
benzene and water was removed azeotropically.
water was collected.

Only a trace amount of

No product was obtained in this experiment.

The

differences in properties between 2, 4-dimethyl-6-hydroxy-pyrimidine
(XXXIV) and uracil were studied:
a.

2, 4-Dimethyl-6-hydroJcy"-pyrimidine is soluble in hot benzene
and uracil is not. Thus, potassium salt formation of the
former would take place more readily than of the latter.

b. In the anion of the potassium salt of 2, 4-dimethyl-6hydroxy-pyrimidine (XXXV), there _are electron r�leasing
substituents, methyl groups, at the 2- and 4-positions.
The methyl groups would increase the basic strength of
the anion of the salt and increase the nucleophilic dis
placement reaction. In the anion of the mono-potassium
salt of uracil, there are no electron releasing methyl
groups.
The reason that the method of synthesizing O, O-diethyl, 0-(2, 4-di
methyl-6-pyrimidyl) phosphate (�XXVI) could not be applied to the
synthesis of 0, 0, 0,0-tetraethyl, O, O-pyrimidine-2,4-yl diphosphate ·
might be due to these differences.

A reaction between the mono

sodium salt of uracil (XXXVII) and diethyl phosphorochloridate in
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benzene has been attempted (39) with no product obtained.

T his seems

to indicate that the second difference ( b. ) is more important.

XXXVII
In the .di-sodium salt of uracil ( XXVII) , the anion on the 2carbon - is more basic and thus would be more readily attacked by the
nucleophilic agent than the anion on the 4-carbon (Fig. 8).

In this

experiment, uracil was obtained as the product when treated with water.
To explain this, the assumption was made that the monophosphorylated
compound (XXVIII) was obtained but was not stable in the presence of
water (Fig. 18).
ON a

N�

� (1.N
EtO-��

OEt

J

)

+

EtO-P-ONa
I
II

OEt

XXVIII
Fig. 18 Hydrolysis of sodium salt of 0, 0-diethyl, 0-( 4-hydroxy2-pyrimidyl) phosphate
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EXPERIMENTAL
All melting points recorded in this work were taken using a
capillary tube melting point apparatus ( Tottoli) and are uncorrected.
To determine silver content, the silver compound was titrated with
ammonium thiocyanate using ferric ammonium sulfate as the indicator .
Nitrogen content was determined. by the Kjeldahl semi-micro method .
PREPARATION OF URACIL (21) :
Thirty percent fuming sulfuric acid (1080 gm. , 600 ml. ) was
diluted with 95 percent sulfuric acid (4o2 gm. , 225 ml. ) to make 15
percent fuming sulfuric acid ( 1482 gm. , 825 ml. ).

In a 5000-ml. ,

round-bottomed, three-necked flask fitted with an efficient mechanical
stirrer and a thermometer was placed the 15 percent fuming sulfuric acid (1304 gm. , 800 ml. ) which was chilled to o0 in a freezing
mixture.

Into the flask, crystalline urea (200 gm. , 3. 20 mole) was

added gradually with stirring at a rate . to keep the temperature
below 10°.

This step required one hour .

Pulverized commercial malic

acid (200 gm. , 1. 50 mole) was then added at once and the flask was
fitt�d with a water-cooled condenser and heated on the steam-bath
for one hour.

During the first 15 minutes, large volumes of carbon

monoxide, carbon dioxide and sulfur dioxide were evolved.

At the end

of the heating period, the flask was cooled and its contents were
poured into ice water (2400 ml. ) .

On cooling , the crude uracil

; /

separated.
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The yield of the crude product was 123 - gm.. ( 65 . 3%). The

uracil was washed with water (suspended in wat·er and again filtered)
and recrystallized from boiling water (2500 ml. ) with the aid of
charcoal (20 gm.) . After drying at 100° . for four hours, the recrys.
tallized product weighed 96. 4 gm. , which was 51 . 2 percent of the
'

theoretical amount and melted at 333-335

°

( reported :

yield,· 50-55%,

m.p. JJ5°)

PREPARATION OF 2,4-DICHLOROPYRIMIDI�E '( 18. 40) :
, � mixture of uracil (25.0 gm. , o.445 mole) ; phosphorus oxychloride
(125

m1. ;

1.40 mole) and N, N-dimethylaniline (31 ml., 0.24 mole) was

refluxed for two hours.

The dark brown homogeneous solution was cooled

and most of the excess phosphorus oJcyTchloride was distilled under
reduced pressure. Crushed ice (180 gm.) was then gradually added to
the dark-colored viscous residue with vigorous stirring.

T he temper- .

ature of the mixtu-re was kept below 200 during this treatment because
of the ease of hydrolysis of the dichloropyrimidine to uracil. After
five minutes, ether (250 ml.) was added.

The ether layer was washed

with four 50-ml. portions of water and dried over anhydrous sodium
sulfate.

The ether was removed by distillation and the residue was

· distilled under reduced pressure.

The product, 2, 4-dichloropyrimidine,

was collected as colorless crystals at 88° /17 mm. The yield of the

· product was 23 gm. (7of,), m. p. 60-62° ( reported:
61-62°, b.p. 100° /22 nnn.).

yield, 871, , m.p.
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PREPARATION OF SILVER DIETHYL PHOSPHATE ( 22, 23, 27, 41):
In a 500-ml. , round-bottomed flask (with condenser), a mixture
of triethyl phosphate ( 90 gm. , o.49 mole) , barium hydroxide octa
hydrate, and water (200 ml.) was refluxed for one and one-half; hours.
The hot mixture was saturated with carbon dioxide, cooled and filtered.
The filtrate was concentrated to a small volume and diluted with eth
anol to give barium tetraethyl diphosphate.

After filtering and drying,

the crude product weighed 59.4 gm. (57.6%) .

To obtain a pure product ,

the crude barium salt was dissolved in a minimum amount of hot water
and hot ethanol (2000 ml.) was added. The water-ethanol solution was
cooled slowly and the barium salt precipitated out in white, shining
needle-form crystals. The yield of the recrystallized product , which
does not melt over a flame, was 47 . 7 gm. (46 � 3%).

Twenty m.1.. of 50

percent silver nitrate solution containing 10. gm. (0.060 mole) and 60
ml. of 3. 8 percent sodium hydroxide solution containing 2.3 gm.
(0. 060 mole) were prepared with carbon dioxide free water and mixed.
The precipitate of silver oxide ( 6. 9 gm. , 9.060 mole) was washed with
carbon dioxide free water by decantation.

The recrystallized barium

tetraethyl phosphate (13.2 gm. , 0.0298 mole) was decomposed by the
theoretical amount of sulfuric acid ( 58 . 30 ml. , 1.024 N, 0. 02900 mole)

with stirring, care being taken to avoid an excess · of acid.

After

20 minutes, the suspension was filtered through a Buchner funnel
which was precoated with a bed of Filteraid to remove the barium
sulfate.

The filtrate was neutralized by the freshly prepared silver

oxide (6. 9 gm., 0.060 mole) in the dark.

The neutralized solution
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(pH

5 ) was evaporated in vacuo to give a white waxy product of silver

diethyl phosphate which weighed 16. 0 gm. ( 100%) , m. p. 115-150°.

The

�ilver salt was recrystalliz·e d from purified dioxane and stored in
the dark.

The yield of the recrystallized product (white, shining,

needle-form crystals) was 12. 0 gm. ( 75%), m.p. 150-155 °.
content of the salt was 41. 08 percent (theoretical:

Silver

41. JJ percent) .

ATTEMPTED PREPARATI0N' 0F o.o, o, o-TETRAETHYL, 0, 0-PYRIMIDINE-2,
4-YL· DIPHOSPHATE (19) :
A.

Benzene as solvent :
In the dark, 2 , 4-dichloropyrimidine ( J. O gm. , 0. 020 mole) ,

freshly prepared silver diethyl phosphate (15. 8 gm. , 0. 0605 mole) ,
anhydrous calcium sulfate (5. 0 gm. ) and benzene (60 ml. ) were placed
in a 250-ml. , round-bottomed flask with condenser.

The mixture was

warmed at 50° for JO minutes and then heated to reflux for one and
one-half hours.

Vigorous stirring was ma'intained throughout.

After

cooling, the reaction mixture was suction-filtered through a B;;chner
funnel.

The benzene was removed from the filtrate by distillation

on a water bath under water pump pressure.

The resulting yellow

syrup ( 1. 5 gm. ) gave a positive test for silver ion and turned to
bluish-purple on exposure to light.

The pale yellow residue from the

filtration, which also turned bluish-purple on exposure to light, was
extracted with three 50-ml. portions of hot acetone and the extract
was evaporated in vacuo to a small volume.
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Skelly B (-400 ml. ) was added to the syrup to induce - crystallization.
No crystalline product was obtained except a trace amount of impurity.
No product could be isolated . from the reaction mixture .
B�

Dioxane as solvent :
In an Ehrlenmeyer flask (�th condenser) . · silver di�thyl

phosphate (1 gm., 0 .004 mole) and purified dioxane (100 ml . ) were
· heated in the dark.

After · the silver sa�t dissolved, 2, 4-dichloro-

pyrimi_dine (O . J

0. 002 mole) was added .

gm. ;

The colorless dioxane

· solution turned yellow with some black precipitate in a few minutes
af't�r reflux started .

The same result was obtained in about one hour

if the temperature was kept around 60 ° .

The fact that �.. in the absence

of 2, 4-dichloropyrimidine, a dioxane solution of the silver salt
changed from colorless to light red with a black precipitate after
being heated at 60° for three hours led to the conclusion that the
silver salt was not stable in purified dioxane and dioxane would not
be useful as the solvent in this reaction-.
C. Without any solvent :
A mixture of silver diethyl phosphate ( 1 gm., 0 . 004 mole) and
°

2, 4-dichloropyrimidine (O . J gm . , 0. 002 mole) was heated at 135 on a
wax bath overnight .

The soft solid was extracted with purified

dioxa.ne (50 ml . ) and filtered.

The solvent was removed from the
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filtrate under reduced pressure and a small amount of yellow syrup was
left.

The syrup did not solidify on cooling and gave a negative test

for silver ion.

The same result was observed when the mixture was

heated at 155 ° for six hours.

The two different ways of heating were

also applied to a mixture of silver diethyl phosphate (0. 5 gm. , 0.002
mole) and 2, 4-dichloropyrimidine (0.3 gm. , 0.002 mole) .

The same

results were obtained.
ATTEMPTED PREPARATION OF TETRASILVER ,·o, O-PYRIMIDINE-2, 4-YL
DIPHOSPHATE (19, 24) :

A.

B�nzene as solvent:
In the dark, 145 ml. of normal hydrated trisodium orthophos-

phate solution containing 18. 0 gm. (0. 0421 mole) was poured into 150 ml.
of normal silver nitrate solution containing 25 . 0 gm. (0. 148 mole) .
The yellow precipitate of trisilver phosphate was collected by suction
filtration, washed with water, dried in ·the oven (105 °) to constant
weight and stored in the dark.

In a 250-ml., round-bottomed flask

fitted with a water-cooled condenser, an efficient mechanical stirrer
and an inlet tube for nitrogen were placed 2, 4-dichloropyrimidine
( 2. 50 gm . , 0 . 0168 mole) , the freshly prepared silver phosphate (17. 0
gm . , 0. 0410 mole) and benzene ( 50 ml. ) .

The mixture was refluxed

·with stirring in an atmosphere of nitrogen for 24 hours in the dark.
After being cooled to room temperature, the mixture was filtered.

Jl
The yellow residue was not soluble in water but soluble in ammonium
hydroxide (silver phosphate?) .
filtrate.

The benzene was removed from the

The appearance and the melting point (57-61°) of the

yellow solid residue, which weighed 2. 6 gm. , indicated that the resi
due was the starting material, 2, 4-dichloropyrimidine .
B.

Without any solvent:
In the . dark, freshly prepared dry silver phosphate (17. 0 gm. ,

0. 041 mole) and 2, 4-dichloropyrimidine ( 2. 5 gm. , 0. 0168 mole) were
placed in a 50-ml. , round-bottomed, two-necked flask fitted with an
inlet tube for nitrogen , air-cooled condenser, and a gas outlet and
heated at 120° in an atmosphere of nitrogen overnight.

This method

was not successful apparently because of the sublimation of the
dichloropyrimidine onto the cooler upper area of the reaction appa
ratus at this reaction temperature.

ATTEMPTED PREPARATION OF TErRASODIUM� O,O-PYRIMIDINE-2,4-YL
DIPHOSPHATE ( 19) :
Trisodium orthophosphate duodecahydrate (35. 7505 gm. ) was dried
in the oven ( 105° ) to constant weight (18. 7.545 gm. , i. e. 1. 592 moles
water of hydration/mole).

In

a 100-ml. ,

round-bottomed flask fitted

with condenser were placed the dried s odium phosphate (7 .10 gm. ,
0. 0353 mole) , 2, 4-dichloropyrimidine (2. 50 gm . , 0. 0168 mole) and
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redtstilled xylene ( 50 ml. ). With stirring, �he mixture was heated
to reflux for 12 hours.

Aft�r cooling, the reaction mixture was

filtered with suction.

The 'residue ( 7. 5 gm.) gave a negative test

for chloride and was extracted with three 50-ml. portions of hot
alcohol.

The solvent was removed from the extract and only a trace

amount of yellowish solid impurity was left.

The xylene was distilled

under reduced pressure from the_filtrate and the appearance and the
melting point (56-62°) of the yellow solid residue, which weighed
2_.7 gm . , indicated that the residue was the starting material, 2, 4dichloropyrimidine.

ATTEMPTED PREPARATION OF 2,4-DIIOOOPYRIMIDINE:
A. Acetone as solvent ( 28) :
Sodium iodide was dried in the oven ( 110 °) for two hours.

A

mixture of anhydrous sodium iodide ( 9.1 gm • • 0. 064 mole) and 2, 4-di
chloropyrimidine ( 1. 48 gm. , 0. 0100 mole) in redistilled acetone
(200 ml.) was refluxed for 48 hours.

Arter cooling , the reaction

mixture with a trace amount of precipitate was filtered.

The acetone

solution was evaporated in vacuo and the residue was extracted with
hot anhydrous benzene ( 100 ml.).
at reduced pressure.

The benzene extract was concentrated

The product distilling at 85° /15 mm. was col

lected and weighed 0. 5 gm. , m. p. 60-62° ( reported :
pyrimidine melts at 61-62°) .

2, 4-dichloro

JJ
B.

2-Butanone as solvent (25, 42):
A mixture of anhydrous sodium iodide (8. 0 gm. , 0. 054 mole) and

2-butanone· ( 70 ml. ) was heated on a steam bath for one hour with a
water-cooled reflux condenser.

2, 4-Dichloropyrimidine (2. 0 gm. , 0. 0lJ

mole) was added to the mixture and heating was maintained for an addi
tional 48 hours with occasional._ shaking.

The reaction mixture with

a trace amount of precipitate was cooled to room temperature and
filtered through a Buchner funnel with suction.
washed. with 2-buta.none (15 ml. ) .

The residue was

The butanone solution was evaporated

in vacuo and the residue was extracted with hot benzene (100 ml.. ) .
The benzene extract was evaporated under reduced pressure and the
product boiling at 87° /15 mm. was collected and weighed 0 . 5 gm. , m. p.
60-62° (reported:

2, 4-dichloropyrimidine melts at 61-62 ° ).

ATTEMPTED PREPARATION OF 0,0-DIETHYL, 0-( 2-HYDROXY-4-PYRIMIDYL)
PHOSPHATE (20) :
In a 100-ml. , round-bottomed, three-necked flask fitted with an
efficient mechanical stirrer , a reflux condenser and inlet of nitrogen
gas were placed uracil (11. 2 gm. , 0 . 100 mole) , potassium carbonate
{14. o gm. , 0. 100 mole) and benzene (25 ml. ) .

The mixture was refluxed

for three hours with stirring and the small amount of water formed was
removed by azeotropic distillation.

Diethyl phosphorochloridate (19. 0

gm. , 0.110 mole) was then added and the mixture was refluxed for eleven

hours.

The - suspension was allowed to cool to room -temperiture and

filtered with suction. · The residue was washed with benzene.

The

filtrate ·and the washings were combined and washed with five percent

potassium carbonate (20 ml.) and two 20-ml. portions of water and
dried over sodium sulfate overnight.

The syrup (3 gm. ) obtained

on solvent removal did not solidify on cooling.

The filter cake was

extracted with three 50-ml. po �tions of hot acetone, th�ee 50-ml.

portions of hot chlorofo�, ancf three 50-ml. portions of hot dioxane.

· Only trace amounts of impurity (syrup) �th strong odor ( garlic-like)

·were obtained after each solvent fraction was evaporated under reduced
pressur�.

The residue was also extracted with three 50-ml. portions

ot hot alcohol and a trace amount of white crystals precipitated in
the alcohol extract on cooling. A Kjeldahl determination indicated
that these white crystals contained no nitrogen.

No product could

be isolated from the reaction mixture •
. . ATTEMPTED PREPARA TION OF O. 0-DIE'THYL, 0-( 4-HYDROXY-2-PYRil1IDYL
PHOSPHATE (20, 42) :
Uracil (11.2 gm. , 0.100 mole) was added to a solution of sodium
hydroxide ( 187 ml . , 1. 07 N • 0. 200 mole) • A fter heating for onehalf hour, the solvent was evaporated under reduced pressure and the
residue (disodium salt of uracil) was dried in the vacuum oven for
four hours .

The dried product weighed 17. 9 gm. (115% apparent yield)

and did not melt over a flame.

In a three-necked, round-bottomed flask

fitted with an efficient mechanical stirrer and water-cooled condenser,
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the disodium · salt of uracil ( 10. 0 gm. , 0. 0641 mole) , diethyl phos
phorochloridate (11.1 gm. , 0.0641 mole), mercurous chloride ( 0. 300 gm. ,
0.00110 mole) and benzene ( 100 ml. ) were heated to reflux for 12
hours.

The reaction mixture was cooled and filtered.

The dried

re·sidue wa.s washed by suspending in water with stirring and then
filtered.

The insoluble residue (7.9 gm. ) melted at 320-335° .

This

indicated that the residue was the starting material, uracil, with
some impurity.

/

-,

RESULTS AND CONCLUSIONS
According to the procedure of Davidson and Bandisch, uracil
was synthesized in a yield of 51 percent ( reported yield:

50-55

percent) ; following the method of Whittaker , 2, 4-dichloro-pyri�
i

midine was synthesized with a yield of 70 p�rcent ( reported yield :
87 percent).

Various methods w�re applied to the uracil and the

dichloropyrimidine to test the feasibility of phosphate formation of
�racil .

All of the attempts were unsuccessful.

The first synthetic route (Fig. 7) was planned according to
the aliphatic property of 2 , 4-dichloropyrimidine and the negative
results indicated that the chloro groups at the 2- and 4-positions
of the dichloropyrimidine were not reactive enough toward nucleo
philic substitution reactions in comparison with chloro groups in
alkyl chlorides.

The introduction of the fluoro group . a highly

electronegative group . at the 5-position would withdraw electrons
by an inductive mechanism and activate the substituents ·at the 2- and
4-positions (44).

By

the activating effect of the fluoro group, the

phosphate formation ( XIV) from 2, 4-dichloro-5-fluoropyrimidine and
the metal salt of dialkyl phosphoric acid may be possible.
In the second synthetic route (Fig. 8) , uracil was used as the
starting material.

Although 5-fluorouracil is bio-isosteric to uracil,

the introduction of a fluoro group at the 5-position has a great effect
on the electron distribution in the molecule and thus , the acid
strength of 5-fluorouracil is JO times that of uracil (2) .

Although

J?
with the higher acidity, 5-fltiorouracil forms a potassium salt more
readily than uracil, the fluoro group would delocalize the ne gative
�barge on the o,cjTgen of the anion of the potassium salt (XXXVIII) and
thus, would stabilize the anion and reduce its basic strength.

XXXV III
Since the anion of the mono-potassium salt of uracil (XXI I) appeared
to be too weakly basic to react with diethyl phosphorochloridate, it
seems �even less possible to synthesize O, O, O, O-tetraethyl, 0,0-(5fluoropyrimidine-2, 4-yl) diphosphate (XIV) by this method.
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